指南与共识重症综合管理与镇静镇痛消化、代谢与肾脏急症

儿童、青少年及年轻成人肝窦阻塞综合征的诊断、分级与治疗推荐:国际专家立场声明

Diagnosis, grading, and treatment recommendations for children, adolescents, and young adults with sinusoidal obstructive syndrome: an international expert position statement.
指南 / 共识 · Lancet Haematol · 2019-12-07
一句话结论国际专家小组推荐普遍采用EBMT儿童肝窦阻塞综合征诊断指南,并提供严重度分级与防治的实施指导。

该国际专家立场声明针对接受造血干细胞移植的儿童、青少年及年轻成人肝窦阻塞综合征(又称肝静脉闭塞病),指出历史Baltimore和Seattle标准因儿童与成人在遗传易感性和临床表现上的差异而不充分。2017年EBMT提出了首个儿童诊断与严重度分级指南。专家小组于2019年2月在美国德克萨斯大学MD Anderson癌症中心开会评估证据,形成共识推荐:普遍采用EBMT儿童诊断指南并提供标准化实施指导,提出使用与年龄相适应的器官特异性毒性标准辅助严重度分级,并给出预防和治疗考虑。关键推荐涉及不常规用肝活检、门静脉楔压和多普勒超声门静脉血流反向诊断,以及血小板输注无效、肝大和腹水的定义。

要点

  • 推荐普遍采用EBMT提出的儿童肝窦阻塞综合征诊断指南,并提供跨中心标准化的实施指导。
  • 肝活检、门静脉楔压及多普勒超声门静脉血流反向不应用于儿童、青少年和年轻成人肝窦阻塞综合征的常规诊断。
  • 血小板输注无效可定义为至少连续两次ABO相容新鲜血小板输注后校正计数增量低于5000-7500。
  • 肝大最好定义为锁骨中线肝长度绝对增加至少1 cm;无基线值时定义为大于同龄正常值2个标准差以上。
  • 腹水存在和容量可分为轻度(肝、脾或盆腔少量液体)、中度(液体<1 cm)或重度(三个区域均有液体且至少两个区域液体>1 cm)。

适用人群与场景

  • 接受造血干细胞移植的儿童、青少年及年轻成人肝窦阻塞综合征患者。

诊断标准与关键阈值

  • 推荐普遍采用EBMT提出的儿童肝窦阻塞综合征诊断指南。
  • 血小板输注无效:至少连续两次ABO相容新鲜血小板输注后校正计数增量低于5000-7500。
  • 肝大:锁骨中线肝长度绝对增加至少1 cm;无基线测量时,大于同龄正常值2个标准差以上。
  • 腹水:轻度为肝、脾或盆腔少量液体;中度为液体<1 cm;重度为三个区域均有液体且至少两个区域液体>1 cm。
  • 提出使用与年龄相适应的器官特异性毒性标准辅助严重度分级。

处置流程与药物剂量

  • 提供EBMT儿童诊断指南跨中心标准化实施的指导。
  • 提供儿童、青少年及年轻成人肝窦阻塞综合征的预防和治疗考虑。
  • 肝活检、门静脉楔压及多普勒超声门静脉血流反向不应用于常规诊断。

研究设计与关键结果

  • 国际专家小组由造血干细胞移植、儿科重症、肾脏病、肝病、放射、病理和输血医学专家,造血干细胞移植高级实践提供者和医学受训者,药师,以及转化和基础科学研究人员组成,来自儿童急性肺损伤和脓毒症研究者网络、EBMT、儿童血液和骨髓移植联盟及其他机构。
  • 专家小组于2019年2月在美国德克萨斯州休斯顿市德克萨斯大学MD Anderson癌症中心开会评估现有证据。
  • 声明提供儿童、青少年及年轻成人肝窦阻塞综合征诊断、严重度分级和治疗的共识推荐。

证据类型、等级与局限

  • 证据类型:国际专家立场声明(共识推荐)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 推荐普遍采用EBMT儿童肝窦阻塞综合征诊断指南,并提供实施指导以促进跨中心标准化。
  • 不将肝活检、门静脉楔压和多普勒超声门静脉血流反向用于儿童、青少年和年轻成人肝窦阻塞综合征的常规诊断。
  • 使用上述血小板输注无效、肝大和腹水的定义标准。
  • 提出使用与年龄相适应的器官特异性毒性标准辅助严重度分级,并提供预防和治疗考虑。

指南或共识出处

  • 国际专家立场声明:儿童、青少年及年轻成人肝窦阻塞综合征的诊断、分级与治疗推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Sinusoidal obstructive syndrome, also known as hepatic veno-occlusive disease, is a potentially life-threatening complication that occurs in children undergoing haemopoietic stem-cell transplantation (HSCT). Differences in the incidence of genetic predisposition and clinical presentation of sinusoidal obstructive syndrome between children and adults have rendered the historical Baltimore and Seattle diagnostic criteria insufficient for children. In 2017, the European Society for Blood and Marrow Transplantation (EBMT) proposed the first paediatric diagnostic and severity grading guidelines for sinusoidal obstructive syndrome, intended for implementation across European centres. However, universally accepted paediatric criteria are needed to ensure prompt diagnosis, definitive treatment, and improved outcomes for children, adolescents, and young adults with sinusoidal obstructive syndrome, and to facilitate international clinical research collaboration. We convened an international panel of multidisciplinary experts including physicians with expertise in HSCT, paediatric intensive care, nephrology, hepatology, radiology, pathology, and transfusion medicine; HSCT advanced-practice providers and medical trainees; pharmacists; and translational and basic science researchers from the Pediatric Acute Lung Injury and Sepsis Investigators Network, the EBMT, the Pediatric Blood and Marrow Transplant Consortia, and several other institutions with extensive experience in sinusoidal obstructive syndrome. Panellists convened at The University of Texas, MD Anderson Cancer Center (Houston, TX, USA) in February, 2019, to evaluate the available evidence. In this expert position statement paper, we provide consensus recommendations for the international implementation of guidelines for the diagnosis, severity grading, and treatment of sinusoidal obstructive syndrome among children, adolescents, and young adults. We endorse universal adoption of paediatric diagnostic guidelines for sinusoidal obstruction syndrome as proposed by the EBMT, and provide implementation guidance for standardisation across centres; we have further proposed adjunctive use of age-appropriate organ-specific toxicity criteria for severity grading and provided prophylaxis and treatment considerations among children and adolescent and young adult patients. Key recommendations include: (1) liver biopsy, portal venous wedge pressure, and reversal of portal venous flow on Doppler ultrasonography should not be used for the routine diagnosis of sinusoidal obstructive syndrome in children, adolescents, and young adults; (2) platelet refractoriness can be defined as a corrected count increment of less than 5000-7500 following at least two sequential ABO-compatible fresh platelet transfusions; (3) hepatomegaly is best defined as an absolute increase of at least 1 cm in liver length at the midclavicular line; and if a baseline measurement is not available, hepatomegaly can be defined as greater than 2 SDs above normal for age; and (4) the presence and volume of ascites can be categorised as mild (minimal fluid by liver, spleen, or pelvis), moderate (<1 cm fluid), or severe (fluid in all three regions with >1 cm fluid in at least two regions).

来源:Lancet Haematol,查看原文。版权归原作者所有。

参考来源

  1. Mahadeo KM, Bajwa R, Abdel-Azim H, et al. Diagnosis, grading, and treatment recommendations for children, adolescents, and young adults with sinusoidal obstructive syndrome: an international expert position statement. Lancet Haematol. 2019. PMID: 31818728. doi:10.1016/S2352-3026(19)30201-7

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。